Cargando…
Cave Microbiomes: A Novel Resource for Drug Discovery
This book details recent findings in the field of cave microbiology and builds on fast-paced efforts to exploit an unconventional and underexplored environment for new microorganisms which may provide an untapped source of drugs: microorganisms from caves.
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2013.
|
| Edición: | 1st ed. 2013. |
| Temas: | |
| Acceso en línea: | Texto Completo |
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-1-4614-5206-5 | ||
| 003 | DE-He213 | ||
| 005 | 20220113090541.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 121009s2013 xxu| s |||| 0|eng d | ||
| 020 | |a 9781461452065 |9 978-1-4614-5206-5 | ||
| 024 | 7 | |a 10.1007/978-1-4614-5206-5 |2 doi | |
| 050 | 4 | |a QR46 | |
| 072 | 7 | |a MMFM |2 bicssc | |
| 072 | 7 | |a MED052000 |2 bisacsh | |
| 072 | 7 | |a MKFM |2 thema | |
| 082 | 0 | 4 | |a 616.9041 |2 23 |
| 245 | 1 | 0 | |a Cave Microbiomes: A Novel Resource for Drug Discovery |h [electronic resource] / |c edited by Naowarat Cheeptham. |
| 250 | |a 1st ed. 2013. | ||
| 264 | 1 | |a New York, NY : |b Springer New York : |b Imprint: Springer, |c 2013. | |
| 300 | |a XIII, 130 p. 58 illus., 38 illus. in color. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 505 | 0 | |a Advances and Challenges in Studying Cave Microbial Diversity -- Cave Biofilms and Their Potential for Novel Antibiotic Discovery -- Cave Conservation: A Canadian caver's Perspective -- Cave Conversation: A Microbiologist's Perspective -- Microbial Ecology: Caves as an Extreme Habitat -- Studies of Antibiotic Production by Cave Bacteria. . | |
| 520 | |a This book details recent findings in the field of cave microbiology and builds on fast-paced efforts to exploit an unconventional and underexplored environment for new microorganisms which may provide an untapped source of drugs: microorganisms from caves. | ||
| 650 | 0 | |a Medical microbiology. | |
| 650 | 0 | |a Immunology. | |
| 650 | 0 | |a Environment. | |
| 650 | 0 | |a Medicine-Research. | |
| 650 | 0 | |a Biology-Research. | |
| 650 | 1 | 4 | |a Medical Microbiology. |
| 650 | 2 | 4 | |a Immunology. |
| 650 | 2 | 4 | |a Environmental Sciences. |
| 650 | 2 | 4 | |a Biomedical Research. |
| 700 | 1 | |a Cheeptham, Naowarat. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9781461452072 |
| 776 | 0 | 8 | |i Printed edition: |z 9781461452058 |
| 856 | 4 | 0 | |u https://doi.uam.elogim.com/10.1007/978-1-4614-5206-5 |z Texto Completo |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||